Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07471633 · ClinicalTrials.gov registry record · NA
Piloting a Learning Collaborative for School-Based Bilingual Providers Delivering Evidence-Based Interventions
A NA study, sponsored by University of Oregon.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07471633: Clinical Trial NA study, sponsored by University of Oregon.
NCT07471633 is a NA study that has not yet begun recruiting, run by University of Oregon. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07471633, a NA study, has not yet begun recruiting, sponsored by University of Oregon.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This pilot feasibility trial is designed to evaluate an adapted Learning Collaborative (LC) as an implementation strategy to support delivery of the Supporting Transition Resilience of Newcomer Groups (STRONG) intervention in school settings serving newcomer youth. The LC will support bilingual school-based mental health providers delivering STRONG, a group-based, school-delivered behavioral intervention targeting stress, anxiety, depressive symptoms, and externalizing behaviors among newcomer middle school students. STRONG will be facilitated by bilingual providers with participating students and their caregivers completing pre- and post-intervention surveys assessing youth emotional and behavioral well-being. The primary aim is to assess the feasibility, acceptability, and appropriateness of the LC for supporting school-based implementation of STRONG, with feasibility measured by participation in LC activities and completion of implementation supports, and acceptability and appropriateness assessed through provider and leader feedback. Secondary aims include examining whether provider and school leader engagement in LC activities is associated with STRONG implementation fidelity and youth outcomes, and exploring potential mechanisms linking LC engagement to fidelity, including provider self-efficacy, leadership support, and team psychological safety. School-based providers and school leaders (e.g., principals and superintendents) will participate in LC activities focused on shared learning, collaboration, and implementation problem-solving, along with ongoing supports such as structured team support calls, Plan-Do-Study-Act (PDSA) cycles, and feedback forms during STRONG implementation cycles.
Primary Outcome
To access feasibility of the LC, school mental health providers and school leaders will complete the Feasibility subscale from the Acceptability, Feasibility \& Appropriateness measure. The response scale is 1 = not at all, 3 = moderately, 5 = extremely.
Interventions
- BEHAVIORAL Learning Collaborative
- BEHAVIORAL STRONG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What is known before NCT07471633 opens enrollment
NCT07471633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Learning Collaborative is the first listed.
NCT07471633 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07471633 about?
NCT07471633 is a clinical study titled "Piloting a Learning Collaborative for School-Based Bilingual Providers Delivering Evidence-Based Interventions". This pilot feasibility trial is designed to evaluate an adapted Learning Collaborative (LC) as an implementation strategy to support delivery of the Supporting Transition Resilience of Newcomer Groups (STRONG) intervention in school settings serving newcomer youth. The LC will support bilingual scho...
What is the current status of trial NCT07471633?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-06-01. Estimated completion is 2027-01-31.
What interventions are being tested in trial NCT07471633?
The interventions under investigation include: Learning Collaborative (BEHAVIORAL), STRONG (BEHAVIORAL).
Who is sponsoring clinical trial NCT07471633?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07471633's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI